|
|
Other links at Articles > Business of Medicine |
| 1. |
India Asks Drug Makers to Lower Prices
|
|
|
Pharmaceutical companies will have to lower prices on most of the non-scheduled drugs by 4.58 percent following duty cuts in the federal budget, the National Pharmaceutical Pricing Authority (NPPA) said on Monday. Reuters Health Information
|
| 2. |
Tenet to Sell Broadlane Stake, Proceeds $155 Mln
|
|
|
Hospital operator Tenet Healthcare Corp said on Monday it will sell its interest in health care services company Broadlane Inc to TowerBrook Capital Partners L.P. for proceeds of about $155 million. Reuters Health Information
|
| 3. |
Poor and Medicaid Recipients With MI Have Longest Prehospital Delays
|
|
|
New research shows that those with Medicaid insurance and those living in low-income neighborhoods are less likely than their better-off counterparts to get to the hospital quickly after an acute MI. This adds to prior studies that have shown that race, sex, age, and comorbid conditions can influence the time taken to get to the hospital following AMI. Heartwire
|
| 4. |
FDA Safety Changes: Cymbalta, Crestor, Rapamune
|
|
|
The FDA has approved revisions to the safety labeling for duloxetine HCl delayed-release capsules, rosuvastatin calcium tablets, and sirolimus tablets and oral solution. Medscape Medical News
|
| 5. |
Eli Lilly to Pay $62 Million in Zyprexa Settlement
|
|
|
Eli Lilly and Co has agreed to pay $62 million to settle claims that it improperly marketed its top-selling Zyprexa schizophrenia drug to patients who were not approved users, the company said on Tuesday. Reuters Health Information
|
|
|
